Home » Topics » BioWorld Science

BioWorld Science
RSS

Selective calcium channel inhibitor blocks hyperalgesia effectively in vivo

May 27, 2004

Benefits associated with IB-MECA in a model of experimental colitis

May 27, 2004

Enrollment completed in ADHD phase II study of NS-2359

May 27, 2004

Pexelizumab reduces events in patients undergoing CABG

May 27, 2004

Liraglutide shows promise in type 2 diabetes

May 27, 2004

Vertex plans METRO study for merimepodib

May 27, 2004

Xanafide enters phase I/II study for metastatic prostate cancer

May 27, 2004

R-115777 active but poorly tolerated in MDS; does not prolong survival with gemcitabine

May 27, 2004

Juvaris enters licensing agreement for new therapeutic vaccine platform

May 27, 2004

Schering-Plough reviews option for intranasal pleconaril

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...